Prototype 400mm x 400mm rastered planar Xray source to allow 3D imaging from planar radiology. Device will be ultra light-weight (

平板X射线源将与现有的数字X射线摄影探测器一起使用。这一转变非常重要，因为当前系统的探测器方面已经进行了重大创新（例如，通过数字射线照相术的进步，例如CMOS探测器），从根本上说，源仍然是与科学博物馆中的源相同的100年前的技术。平面X射线解决方案的成本。当LCD取代真空管时，通过复制在视觉显示单元中看到的转变，我们将：从c. > 200 kg至30%;并且，将维护经济性更改为“固态”设备的维护经济性。同样重要的是，我们将改进平面X射线的功能（提供3D成像），减少辐射负担（通过启用选择性成像），并使在医院外部署X射线放射学更容易。这很重要，因为平面X射线是医学成像的主力，占成像程序的60%-改进其功能并降低其成本对医疗保健至关重要。对这样的产品有需求。该公司与一家大型医学成像公司签订了非排他性合作协议，并利用这种关系来定义市场需求规范。该项目将提供在半导体开发环境中制造的全尺寸（400 mm x 400 mm）固态源，并在临床体模（用于测试此类设备的身体模型）上进行测试。然后，该器械将准备转移到制造环境中，进行CE测试并发布用于商业生产。该公司有一封来自一家半导体制造商的支持信，该制造商有兴趣在英国制造该源。

Flat Panel X-ray Source to be used with existing Digital Radiography detectors.This transformation is important as, while the DETECTOR side of current systems has been significantly innovated (e.g. by advances in Digital Radiography, such as CMOS detectors), the SOURCE is still fundamentally the same 100 year old technology as that in the Science Museum.Current sources typically make up >95% of the weight and >60% of the cost of a planar X-ray solution. By replicating the transformation seen in Visual Display Units when LCD replaced vacuum tubes, we will: reduce the weight of a clinical X-ray source from c. >200kg to 30%; and,change the maintenance economics to those of a 'solid-state' device. As importantly we will improve functionality of planar X-ray (to give 3D imaging), reduce radiation burden (by enabling selective imaging), and make it easier to deploy X-ray radiology outside of a hospital.This is important as Planar X-ray is the work-horse of medical imaging, representing 60% of imaging procedures - improving its functionality and reducing its cost is important to healthcare. There is a demand for such a product. The company has a non-exclusive Collaboration Agreement with a major Medical Imaging company, and this relationship has been leveraged to define the Market Requirement Specification. The Total Addressable Market for such a source is conservatively estimated as exceeding US$1.5bn per anum.This project will deliver a full scale (400mm x 400mm) solid state source manufactured in a semiconductor development environment and tested on a clinical phantom (a model of a body used to test such devices). This device will then be ready to transfer to a manufacturing environment, be CE tested and released for commercial production. The company has a Letter of Support from a semiconductor manufacturer interested in manufacturing the source in the UK.